Research Articles | Page 40 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH) Mar 2025 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index Sep 2020 Leukemia Myelodysplastic Syndromes (MDS)
The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances May 2023 The Cancer Journal Myelodysplastic Syndromes (MDS)
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
The Path to Accessible Care: Development and Impact of Eculizumab Biosimilars for Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome Mar 2025 BioDrugs Paroxysmal Nocturnal Hemoglobinuria (PNH)
The Problem of TP53-Mutant MDS/AML Sep 2020 Clinical Lymphoma , Myeloma & Leukemia Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Oct 2019 Annals of Hematology Myelodysplastic Syndromes (MDS)
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes May 2023 Frontiers in Oncology Aplastic Anemia
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes Dec 2023 Blood Myelodysplastic Syndromes (MDS)
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents Apr 2023 Current Hematologic Malignancy Reports Myelodysplastic Syndromes (MDS)